708 filings
Page 2 of 36
8-K
49vo7u
28 Mar 24
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
4:35pm
8-K
zkbs6q0j4tujijq4
26 Mar 24
Zevra Therapeutics Announces Top-Line Data from the Phase 2 Clinical Trial of
8:28pm
8-K
o986olm
5 Mar 24
Regulation FD Disclosure
7:34am
8-K
9xefy 6tp4u27p
4 Mar 24
Zevra Therapeutics Provides FDA Update on the PDUFA Action Date for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
8:24am
8-K
k7izw8
28 Feb 24
Amendments to Articles of Incorporation or Bylaws
4:29pm
SC 13G
5akg1ozh2 n1mec2h6
14 Feb 24
ZEVRA THERAPEUTICS / Nantahala Capital Management ownership change
4:51pm
8-K/A
7j9ity0
5 Feb 24
Financial Statements and Exhibits
12:00am
4
xzl0gane
2 Feb 24
ZEVRA THERAPEUTICS / Joshua Schafer ownership change
9:22pm
4
hrq5v
2 Feb 24
ZEVRA THERAPEUTICS / Timothy J. Sangiovanni ownership change
8:17pm
4
csxjm
2 Feb 24
ZEVRA THERAPEUTICS / Christal M M Mickle ownership change
8:14pm
4
4enpg s18hs6s6td
2 Feb 24
ZEVRA THERAPEUTICS / Sven Guenther ownership change
8:13pm
4
fa44p4r5setyjzt3lph
2 Feb 24
ZEVRA THERAPEUTICS / R. LaDuane Clifton ownership change
8:11pm
4
8oyvk7w
2 Feb 24
ZEVRA THERAPEUTICS / Neil F. McFarlane ownership change
8:10pm
4
whdg205p i91agdtusla
2 Feb 24
ZEVRA THERAPEUTICS / Alvin Shih ownership change
8:08pm
3
vcjz 7n0s2jrvq0uh
2 Feb 24
ZEVRA THERAPEUTICS / Alvin Shih ownership change
7:13am
SC 13G
mnu4pemj3
29 Jan 24
ZEVRA THERAPEUTICS / BlackRock ownership change
5:25pm
8-K
eczmkc7
23 Jan 24
Departure of Directors or Certain Officers
7:37am
8-K
glvoa737nobm
8 Jan 24
Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C
8:03am
8-K
mpxbtvzlymnb
27 Dec 23
Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
7:48am